CXD101
- Generic Name
- CXD101
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C24H29N5O
- CAS Number
- 934828-12-3
- Unique Ingredient Identifier
- 5TNV87ICD2
- Background
CXD101 is under investigation in clinical trial NCT03873025 (A Study of CXD101 in Combination With Pembrolizumab for Relapsed or Refractory Diffuse Large B-cell Lymphoma).
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath